Drug Developer PPD Targets $1.53B For Public Debut
Private equity-backed drug developer PPD Inc. said Monday it's targeting roughly $1.53 billion at midpoint for its upcoming initial public offering, which is steered by Simpson Thacher and sees Latham &...To view the full article, register now.
Already a subscriber? Click here to view full article